8-K: INVO Fertility Secures $200,000 Investment from Existing Holder
Unregistered Sales of Equity Securities
INVO Fertility, Inc. announced an institutional investor exercised its additional investment right, acquiring $200,000 in Series C-2 Convertible Preferred Stock.
Summary
- An institutional investor, an existing holder of Series C-2 Convertible Preferred Stock (C-2 Preferred) of INVO Fertility, Inc., exercised its Additional Investment Right on July 28, 2025.
- The investor acquired 200 shares of C-2 Preferred, with an aggregate stated value of $200,000, for $200,000 in cash.
- As a result of this exercise, the conversion price on the C-2 Preferred adjusted to $1.8909 per share.
- The C-2 Preferred shares and the common stock issuable upon conversion were sold without registration under the Securities Act, relying on exemptions provided by Section 4(a)(2) and/or Rule 506.
Sentiment
Score: 6
Explanation: The cash infusion is a positive for the company's liquidity, although the adjustment to the conversion price introduces potential future dilution. Overall, it's a routine financing event that provides capital.
Positives
- The company received $200,000 in cash from an existing institutional investor, providing additional capital.
Negatives
- The exercise of the investment right resulted in an adjustment to the conversion price of the C-2 Preferred to $1.8909 per share, which could imply potential future dilution for common shareholders upon conversion.
Stakeholder Impact
- Shareholders: Potential for future dilution due to the adjusted conversion price of the preferred stock.
- Company: Improved liquidity and working capital from the $200,000 cash infusion.
Key Dates
| Date | Description |
|---|---|
| 2024-01-03 | Date of the original Securities Purchase Agreement between the Holder and NAYA Therapeutics Inc. |
| 2024-10-11 | Date INVO Fertility, Inc. became a party to the Securities Purchase Agreement via a joinder agreement. |
| 2025-07-01 | Date of the Current Report on Form 8-K, information from which is incorporated by reference. |
| 2025-07-28 | Date the institutional investor exercised its Additional Investment Right to acquire C-2 Preferred shares. |
| 2025-08-01 | Date the Form 8-K was signed by INVO FERTILITY, INC. |
Recommendation
holdThis filing details a relatively small, pre-arranged capital raise from an existing investor, which provides some cash but also adjusts the conversion price of preferred stock, implying future dilution. It does not present new strategic direction or significant financial performance indicators that would warrant a strong buy or sell recommendation. It's an expected operational financing event.
Keywords
INVO Fertility, IVF, Fertility, Equity Sale, Convertible Preferred Stock, Institutional Investor, Capital Raise, SEC Filing, 8-K
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.